Hennion & Walsh Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
|
|||||
|
2025
Q1 | $1.49M | Sell |
|
|||||
|
2024
Q4 | $2.21M | Buy |
|
|||||
|
2024
Q3 | $3.16M | Buy |
|
|||||
|
2024
Q2 | $2.61M | Buy |
|
|||||
|
2024
Q1 | $2.28M | Buy |
|
|||||
|
2023
Q4 | $1.7M | Buy |
|
|||||
|
2023
Q3 | $1.31M | Buy |
|
|||||
|
2023
Q2 | $899K | Buy |
|
|||||
|
2023
Q1 | $759K | Sell |
|
|||||
|
2022
Q4 | $1.5M | Sell |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $1.46M | Sell |
|
|||||
|
2022
Q1 | $2.48M | Buy |
|
|||||
|
2021
Q4 | $2.16M | Buy |
|
|||||
|
2021
Q3 | $1.98M | Buy |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|
|||||
|
2021
Q1 | $1.14M | Buy |
|